Patient Characteristics at Time of Inclusion
| Variable | Carvedilol M0 | Placebo M0 | P |
|---|---|---|---|
| Age (y) | 59 ± 12 | 60 ± 8 | NS |
| Sex (M/F) | 24/4 | 18/4 | NS |
| Ischemic etiology | 11 | 9 | NS |
| NYHA class II/III | 22/6 | 17/5 | NS |
| ACE inhibitors | 27 | 21 | NS |
| Diuretics | 28 | 22 | NS |
| Systolic arterial pressure (mm Hg) | 120 ± 20 | 123 ± 16 | NS |
| Heart rate (min−1) | 76 ± 11 | 82 ± 13 | NS |
| PHE (%) | 64 ± 9 | 64 ± 6 | NS |
| IPV50 (μL) | 4.3 ± 1.5 | 4.2 ± 1.7 | NS |
| LVEF (%) | 25 ± 11 | 27 ± 12 | NS |
| NE (pg/mL) | 410 ± 181 | 541 ± 284 | 0.05 |
| EDD (mm) | 72 ± 8 | 69 ± 5 | NS |
| ESD (mm) | 59 ± 8 | 55 ± 6 | NS |
EDD = end-diastolic dimension; ESD = end-systolic dimension.